Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Lancet Public Health ; 3(9): e429-e437, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30122559

RESUMO

BACKGROUND: As countries embark on public health-oriented drug law reform, health impact evaluations are needed. In 2012, Mexico mandated the narcomenudeo reform, which depenalised the possession of small amounts of drugs and instituted drug treatment instead of incarceration. We investigated the past and future effect of this drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico. METHODS: In this epidemic modelling study, we used data from the El Cuete IV cohort study to develop a deterministic model of injecting and sexual HIV transmission in people who inject drugs in Tijuana between 2012 and 2030. The population was stratified by sex, incarceration status, syringe confiscation by the police, HIV stage, and exposure to drug treatment or rehabilitation (either opioid agonist treatment or compulsory drug abstinence programmes). We modelled the effect of these exposures on HIV risk in people who inject drugs, estimating the effect of observed and potential future reform enforcement levels. FINDINGS: In 2011, prior to the narcomenudeo reform, 547 (75%) of 733 people who inject drugs in the El Cuete cohort reported having ever been incarcerated, on average five times since starting injecting. Modelling estimated the limited reform implementation averted 2% (95% CI 0·2-3·0) of new HIV infections in people who inject drugs between 2012 and 2017. If implementation reduced incarceration in people who inject drugs by 80% from 2018 onward, 9% (95% CI 4-16) of new HIV infections between 2018 and 2030 could be averted, with 21% (10-33) averted if people who inject drugs were referred to opioid agonist treatment instead of being incarcerated. Referral to compulsory drug abstinence programmes instead of prison could have a lower or potentially negative impact with -2% (95% CI -23 to 9) infections averted. INTERPRETATION: Mexican drug law reform has had a negligible effect on the HIV epidemic among people who inject drugs in Tijuana. However, appropriate implementation could markedly reduce HIV incidence if linked to opioid agonist treatment. Unfortunately, compulsory drug abstinence programmes are the main type of drug rehabilitation available and their expansion could potentially increase HIV transmission. FUNDING: National Institute on Drug Abuse, UC San Diego Center for AIDS Research.


Assuntos
Epidemias , Infecções por HIV/epidemiologia , Legislação de Medicamentos , Saúde Pública/legislação & jurisprudência , Abuso de Substâncias por Via Intravenosa/epidemiologia , Estudos de Coortes , Feminino , Humanos , Incidência , Masculino , México/epidemiologia , Modelos Teóricos
4.
Int J Gynaecol Obstet ; 106(3): 266-9, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19545866

RESUMO

Before 2000, Mexico City's criminal laws prohibited induced abortion to maintain public morality. The Criminal Code considered abortion by accident or in cases of rape not criminal, and criminal but excusable-and therefore not punishable-in certain cases not endangering public morality, such as medical necessity to save the woman's life. In 2000, the Criminal Code was reformed expanding exceptions from criminal liability, particularly in cases of danger to a woman's health or where fetal survival was at risk. In 2004, Mexico City enacted its own law, effectively decriminalizing consensual abortion in cases of rape, fetal malformation, and risk to the woman's health. A 2007 reform further decriminalized all consensual abortion within the first 12 weeks of pregnancy, and required public hospitals to provide abortion and family planning services. In August 2008, the Supreme Court of Mexico ruled Mexico City's 2007 liberalization of abortion law constitutional.


Assuntos
Aborto Legal/legislação & jurisprudência , Política de Saúde/legislação & jurisprudência , Princípios Morais , Serviços de Planejamento Familiar/legislação & jurisprudência , Feminino , Humanos , México , Saúde da Mulher/legislação & jurisprudência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA